Navigation Links
Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society
Date:12/13/2011

sclosed sales milestones, and tiered, double-digit royalties on global revenues.  Ambit also has an option to co-promote products in the U.S. where Astellas and Ambit share equally all profits and losses generated from U.S. sales.

About Ambit Biosciences

Ambit Biosciences is a privately held biopharmaceutical company engaged in the development of a robust pipeline of small molecule kinase inhibitors for the treatment of cancer, inflammatory disease and other indications.  Ambit's lead compound, quizartinib (AC220), is a novel, potent, highly selective, orally bioavailable FMS-like tyrosine kinase-3 (FLT3) inhibitor, and is currently under clinical investigation in patients with relapsed or refractory AML.  Ambit is developing quizartinib in collaboration with Astellas Pharma Inc. as part of a worldwide agreement to jointly develop and commercialize FLT3 kinase inhibitors in oncology and non-oncology indications.  In addition to quizartinib, Ambit's clinical pipeline includes AC430, an oral JAK2 inhibitor, and AC480, a pan-HER inhibitor. Ambit also has a preclinical candidate, CEP-32496, and a BRAF inhibitor licensed to Cephalon.  For more information, visit www.ambitbio.com.

About Astellas

Astellas Pharma Inc., located in Tokyo, Japan, is a pharmaceutical company dedicated to improving the health of people around the world through provision of innovative and reliable pharmaceuticals. Astellas has approximately 16,800 employees worldwide. The organization is committed to becoming a global category leader in Urology, Immunology including Transplantation and Infectious Diseases, Oncology, Neuroscience, and DM complications and Metabolic Diseases. For more information on Astellas Pharma Inc., please visit our website at www.astellas.com/en.

Contacts:
Ambit Biosciences:
Alan Fuhrman
Chie
'/>"/>

SOURCE Ambit Biosciences
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
2. Ambit Biosciences Announces Transition in Company Leadership
3. Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia
4. Astellas Pharma Inc. to Acquire OSI Pharmaceuticals, Inc.
5. Astellas Awards Educational Scholarships to Six Transplant Recipients Who Embody the Spirit of Giving Back
6. Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients
7. CV Therapeutics Board of Directors Rejects Astellas Tender Offer
8. CV Therapeutics Advises Stockholders to Take No Action at This Time in Response to Astellas Tender Offer
9. CV Therapeutics Board of Directors Rejects Astellas Unsolicited Proposal
10. CV Therapeutics Statement on Unsolicited Proposal From Astellas
11. FDA Approves Astellas Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Mo. From cell phones to cars and ... life. Scientists and technology companies constantly are seeking ... for the first time using a water-based solution, ... a long-lasting and more efficient nuclear battery that ... a reliable energy source in automobiles and also ...
(Date:9/16/2014)... Cardioxyl Pharmaceuticals, Inc. announced today ... to be effective in animal models following oral (capsule) ... infusions that could pave the way for convenient outpatient ... at the Heart Failure Society of America,s (HFSA) 18 ... Vegas . The research, conducted in ...
(Date:9/16/2014)... , Sept. 16, 2014  The Council ... entrepreneurial support organization in the country, today released ... Report . It showed that ... North Carolina startups in the technology, ... more global investment from a variety of sources. Significant ...
(Date:9/16/2014)... September 16, 2014 Convoy Therapeutics, ... and effective products to treat patients directly at ... a proprietary SPACE™ Technology Platform announced today that ... will present at the White Hat Life Science ... Hyatt Regency Phoenix. In addition, interested individuals ...
Breaking Biology Technology:Cardioxyl Presents Oral Heart Failure Treatment Data For Its Experimental HNO Prodrug At HFSA 18th Annual Scientific Meeting 2CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 2CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 3CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 4Convoy Therapeutics to Present at WhiteHat Investor Conference September 18, 2014 2Convoy Therapeutics to Present at WhiteHat Investor Conference September 18, 2014 3
... NIH funds human ... ... announced today that it is one of the recipients in a 4-year $1.95M grant from ... evaluate Cell Sense, the Company’s fluorocarbon-based magnetic resonance imaging (MRI) cell tracking reagent, for clinical ...
... vital in helping to save up to 90 per cent ... to scientists. The research team led by Durham ... the UK) looked at the effects of climate change on ... on the network of sites designated for them (termed Important ...
... N.J., June 1 BD (Becton, Dickinson and Company) (NYSE: BDX ), a ... conferences in June: , , Goldman Sachs 30th ... 11:40 a.m. EDT, ... 11, 2009, 10:00 a.m. EDT, , ...
Cached Biology Technology:Celsense, Inc Receives NIH Grant to Translate Cell Imaging Technology for Clinical Use 2Celsense, Inc Receives NIH Grant to Translate Cell Imaging Technology for Clinical Use 3Nature parks can save species as climate changes 2Nature parks can save species as climate changes 3
(Date:9/16/2014)... take up residence in and on the human body ... according to new research at Washington University School of ... individuals carry about five types of viruses on their ... Biology . The study is the first comprehensive analysis ... , The research was conducted as part of ...
(Date:9/16/2014)... The meteorite impact that spelled doom for the dinosaurs ... flowering plants to a much greater extent than their ... researchers. The results are published in the journal ... a treasure trove of thousands of fossilized leaves of ... team was able to reconstruct the ecology of a ...
(Date:9/16/2014)... school year, a new football season and another commercial ... SpaceX,s Dragon spacecraft is scheduled to blast off to ... of the company,s fourth contracted mission to the complex. ... suite of research investigations sponsored by the Center for ... role of managing the U.S. National Laboratory on the ...
Breaking Biology News(10 mins):Healthy humans make nice homes for viruses 2Healthy humans make nice homes for viruses 3Meteorite that doomed dinosaurs remade forests 2Meteorite that doomed dinosaurs remade forests 3Meteorite that doomed dinosaurs remade forests 4CASIS research set for launch aboard SpaceX mission to space station 2CASIS research set for launch aboard SpaceX mission to space station 3
... BROOK, NY, February 20, 2013As the nations of the ... trade in endangered sharks in early March, a team ... the oceanic whitetip shark regularly crosses international ... apex predator within their own maritime borders may therefore ...
... The University of Texas at Arlington are pioneering a new ... make liquid methanol fuel by using copper oxide nanowires and ... expensive than previous methods to convert the greenhouse gas associated ... interim associate vice president for research at UT Arlington and ...
... from 375 past teen participants in a Canadian biotechnology ... -- show a majority of respondents were influenced by ... offering a model for countries worldwide to advance their ... of 375 past participants by Bioscience Education Canada, which ...
Cached Biology News:New research on migratory behavior of oceanic whitetip sharks can help shape conservation strategies 2New research on migratory behavior of oceanic whitetip sharks can help shape conservation strategies 3Researchers say sunlight yields more efficient carbon dioxide to methanol model 2'Inspiring' teens with 'research virus': Expert-mentored bioscience contest proves a powerful vector 2'Inspiring' teens with 'research virus': Expert-mentored bioscience contest proves a powerful vector 3'Inspiring' teens with 'research virus': Expert-mentored bioscience contest proves a powerful vector 4'Inspiring' teens with 'research virus': Expert-mentored bioscience contest proves a powerful vector 5'Inspiring' teens with 'research virus': Expert-mentored bioscience contest proves a powerful vector 6'Inspiring' teens with 'research virus': Expert-mentored bioscience contest proves a powerful vector 7'Inspiring' teens with 'research virus': Expert-mentored bioscience contest proves a powerful vector 8'Inspiring' teens with 'research virus': Expert-mentored bioscience contest proves a powerful vector 9'Inspiring' teens with 'research virus': Expert-mentored bioscience contest proves a powerful vector 10'Inspiring' teens with 'research virus': Expert-mentored bioscience contest proves a powerful vector 11
Acetylcholinesterase from human and monkey....
...
... Dye runs faster than Bromophenol blue,or ... gels.,Orange G dye migrates with DNA ... migration at this size,prevents the obscuring ... the front of DNA migration.,The Orange ...
... solution, Type I is ... and agarose gel electrophoresis ... offers the advantage of ... blue and xylene cyanole). ...
Biology Products: